novo nordisk weight loss news - Search News

Novo Nordisk Posts Mixed Results

Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection will deliver 25% weight loss.

Barron's on MSN · 4d

Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs

A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may have overestimated the market for its new weight-loss and diabetes medicines.

Fast Company · 5d

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked in traditional channels.

6h

Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem ...

Weight-loss pill passes important safety test in clinical trial

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Fortune on MSN5d

Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in Denmark

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results